Cell and Gene Therapy Manufacturing Market

Cell and Gene Therapy Manufacturing Market - Global Industry Assessment & Forecast

Biotechnology and Life Sciences

# Pages:

141

Base Year:

2022

Jul - 2023

Format:

Report Code:

VMR-2227

Segments Covered

By Type Cell Therapy, Gene Therapy
By Indication Oncology Diseases, Inherited Disorders, Cardiovascular Diseases, Musculoskeletal Disorders, Neurological Diseases, Other Indications
By Application Clinical Manufacturing, Commercial Manufacturing
By End User Pharmaceutical & Biotechnology Companies, Contract Manufacturing Organizations (CMOs), Research Institutes & Academic Centers, Regulatory Agencies, Other End Users
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2022
Forecast Years:	2023 - 2030
Historical Years:	2017 - 2021
Revenue 2022:	USD 4.8 Billion
Revenue 2030:	USD 15.4 Billion
Revenue CAGR (2023 - 2030):	18.2%
Fastest Growing Region (2023 - 2030)	Asia Pacific
Largest Region (2022):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Cell and Gene Therapy Manufacturing Market - Segment Analysis
1. Overview
2. Global Cell and Gene Therapy Manufacturing Market, 2016 - 2028 (USD Million)
3. Global Cell and Gene Therapy Manufacturing Market - by Type
  1. By Cell Therapy
  2. By Gene Therapy
4. Global Cell and Gene Therapy Manufacturing Market - by Indication
  1. By Oncology Diseases
  2. By Inherited Disorders
  3. By Cardiovascular Diseases
  4. By Musculoskeletal Disorders
  5. By Neurological Diseases
  6. By Other Indications
5. Global Cell and Gene Therapy Manufacturing Market - by Application
  1. By Clinical Manufacturing
  2. By Commercial Manufacturing
6. Global Cell and Gene Therapy Manufacturing Market - by End User
  1. By Pharmaceutical & Biotechnology Companies
  2. By Contract Manufacturing Organizations (CMOs)
  3. By Research Institutes & Academic Centers
  4. By Regulatory Agencies
  5. By Other End Users
7. Global Cell and Gene Therapy Manufacturing Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
8. Market comparative analysis
North America Cell and Gene Therapy Manufacturing Market - Segment Analysis
1. Overview
2. North America Cell and Gene Therapy Manufacturing Market, 2016 - 2028 (USD Million)
3. North America Cell and Gene Therapy Manufacturing Market, by Type
  1. By Cell Therapy
  2. By Gene Therapy
4. North America Cell and Gene Therapy Manufacturing Market, by Indication
  1. By Oncology Diseases
  2. By Inherited Disorders
  3. By Cardiovascular Diseases
  4. By Musculoskeletal Disorders
  5. By Neurological Diseases
  6. By Other Indications
5. North America Cell and Gene Therapy Manufacturing Market, by Application
  1. By Clinical Manufacturing
  2. By Commercial Manufacturing
6. North America Cell and Gene Therapy Manufacturing Market, by End User
  1. By Pharmaceutical & Biotechnology Companies
  2. By Contract Manufacturing Organizations (CMOs)
  3. By Research Institutes & Academic Centers
  4. By Regulatory Agencies
  5. By Other End Users
7. North America Cell and Gene Therapy Manufacturing Market, by Country
  1. U.S.
    1. U.S. Cell and Gene Therapy Manufacturing Market, By Type
      1. By Cell Therapy
      2. By Gene Therapy
    2. U.S. Cell and Gene Therapy Manufacturing Market, By Indication
      1. By Oncology Diseases
      2. By Inherited Disorders
      3. By Cardiovascular Diseases
      4. By Musculoskeletal Disorders
      5. By Neurological Diseases
      6. By Other Indications
    3. U.S. Cell and Gene Therapy Manufacturing Market, By Application
      1. By Clinical Manufacturing
      2. By Commercial Manufacturing
    4. U.S. Cell and Gene Therapy Manufacturing Market, By End User
      1. By Pharmaceutical & Biotechnology Companies
      2. By Contract Manufacturing Organizations (CMOs)
      3. By Research Institutes & Academic Centers
      4. By Regulatory Agencies
      5. By Other End Users
  2. Canada
    1. Canada Cell and Gene Therapy Manufacturing Market, By Type
      1. By Cell Therapy
      2. By Gene Therapy
    2. Canada Cell and Gene Therapy Manufacturing Market, By Indication
      1. By Oncology Diseases
      2. By Inherited Disorders
      3. By Cardiovascular Diseases
      4. By Musculoskeletal Disorders
      5. By Neurological Diseases
      6. By Other Indications
    3. Canada Cell and Gene Therapy Manufacturing Market, By Application
      1. By Clinical Manufacturing
      2. By Commercial Manufacturing
    4. Canada Cell and Gene Therapy Manufacturing Market, By End User
      1. By Pharmaceutical & Biotechnology Companies
      2. By Contract Manufacturing Organizations (CMOs)
      3. By Research Institutes & Academic Centers
      4. By Regulatory Agencies
      5. By Other End Users
  3. Mexico
    1. Mexico Cell and Gene Therapy Manufacturing Market, By Type
      1. By Cell Therapy
      2. By Gene Therapy
    2. Mexico Cell and Gene Therapy Manufacturing Market, By Indication
      1. By Oncology Diseases
      2. By Inherited Disorders
      3. By Cardiovascular Diseases
      4. By Musculoskeletal Disorders
      5. By Neurological Diseases
      6. By Other Indications
    3. Mexico Cell and Gene Therapy Manufacturing Market, By Application
      1. By Clinical Manufacturing
      2. By Commercial Manufacturing
    4. Mexico Cell and Gene Therapy Manufacturing Market, By End User
      1. By Pharmaceutical & Biotechnology Companies
      2. By Contract Manufacturing Organizations (CMOs)
      3. By Research Institutes & Academic Centers
      4. By Regulatory Agencies
      5. By Other End Users
Europe Cell and Gene Therapy Manufacturing Market - Segment Analysis
1. Overview
2. Europe Cell and Gene Therapy Manufacturing Market, 2016 - 2028 (USD Million)
3. Europe Cell and Gene Therapy Manufacturing Market, by Type
  1. By Cell Therapy
  2. By Gene Therapy
4. Europe Cell and Gene Therapy Manufacturing Market, by Indication
  1. By Oncology Diseases
  2. By Inherited Disorders
  3. By Cardiovascular Diseases
  4. By Musculoskeletal Disorders
  5. By Neurological Diseases
  6. By Other Indications
5. Europe Cell and Gene Therapy Manufacturing Market, by Application
  1. By Clinical Manufacturing
  2. By Commercial Manufacturing
6. Europe Cell and Gene Therapy Manufacturing Market, by End User
  1. By Pharmaceutical & Biotechnology Companies
  2. By Contract Manufacturing Organizations (CMOs)
  3. By Research Institutes & Academic Centers
  4. By Regulatory Agencies
  5. By Other End Users
7. Europe Cell and Gene Therapy Manufacturing Market, by Country
  1. Germany
    1. Germany Cell and Gene Therapy Manufacturing Market, By Type
      1. By Cell Therapy
      2. By Gene Therapy
    2. Germany Cell and Gene Therapy Manufacturing Market, By Indication
      1. By Oncology Diseases
      2. By Inherited Disorders
      3. By Cardiovascular Diseases
      4. By Musculoskeletal Disorders
      5. By Neurological Diseases
      6. By Other Indications
    3. Germany Cell and Gene Therapy Manufacturing Market, By Application
      1. By Clinical Manufacturing
      2. By Commercial Manufacturing
    4. Germany Cell and Gene Therapy Manufacturing Market, By End User
      1. By Pharmaceutical & Biotechnology Companies
      2. By Contract Manufacturing Organizations (CMOs)
      3. By Research Institutes & Academic Centers
      4. By Regulatory Agencies
      5. By Other End Users
  2. UK
    1. UK Market, By Type
      1. By Cell Therapy
      2. By Gene Therapy
    2. UK Market, By Indication
      1. By Oncology Diseases
      2. By Inherited Disorders
      3. By Cardiovascular Diseases
      4. By Musculoskeletal Disorders
      5. By Neurological Diseases
      6. By Other Indications
    3. UK Market, By Application
      1. By Clinical Manufacturing
      2. By Commercial Manufacturing
    4. UK Market, By End User
      1. By Pharmaceutical & Biotechnology Companies
      2. By Contract Manufacturing Organizations (CMOs)
      3. By Research Institutes & Academic Centers
      4. By Regulatory Agencies
      5. By Other End Users
  3. France
    1. France Cell and Gene Therapy Manufacturing Market, By Type
      1. By Cell Therapy
      2. By Gene Therapy
    2. France Cell and Gene Therapy Manufacturing Market, By Indication
      1. By Oncology Diseases
      2. By Inherited Disorders
      3. By Cardiovascular Diseases
      4. By Musculoskeletal Disorders
      5. By Neurological Diseases
      6. By Other Indications
    3. France Cell and Gene Therapy Manufacturing Market, By Application
      1. By Clinical Manufacturing
      2. By Commercial Manufacturing
    4. France Cell and Gene Therapy Manufacturing Market, By End User
      1. By Pharmaceutical & Biotechnology Companies
      2. By Contract Manufacturing Organizations (CMOs)
      3. By Research Institutes & Academic Centers
      4. By Regulatory Agencies
      5. By Other End Users
  4. Spain
    1. Spain Cell and Gene Therapy Manufacturing Market, By Type
      1. By Cell Therapy
      2. By Gene Therapy
    2. Spain Cell and Gene Therapy Manufacturing Market, By Indication
      1. By Oncology Diseases
      2. By Inherited Disorders
      3. By Cardiovascular Diseases
      4. By Musculoskeletal Disorders
      5. By Neurological Diseases
      6. By Other Indications
    3. Spain Cell and Gene Therapy Manufacturing Market, By Application
      1. By Clinical Manufacturing
      2. By Commercial Manufacturing
    4. Spain Cell and Gene Therapy Manufacturing Market, By End User
      1. By Pharmaceutical & Biotechnology Companies
      2. By Contract Manufacturing Organizations (CMOs)
      3. By Research Institutes & Academic Centers
      4. By Regulatory Agencies
      5. By Other End Users
  5. Italy
    1. Italy Cell and Gene Therapy Manufacturing Market, By Type
      1. By Cell Therapy
      2. By Gene Therapy
    2. Italy Cell and Gene Therapy Manufacturing Market, By Indication
      1. By Oncology Diseases
      2. By Inherited Disorders
      3. By Cardiovascular Diseases
      4. By Musculoskeletal Disorders
      5. By Neurological Diseases
      6. By Other Indications
    3. Italy Cell and Gene Therapy Manufacturing Market, By Application
      1. By Clinical Manufacturing
      2. By Commercial Manufacturing
    4. Italy Cell and Gene Therapy Manufacturing Market, By End User
      1. By Pharmaceutical & Biotechnology Companies
      2. By Contract Manufacturing Organizations (CMOs)
      3. By Research Institutes & Academic Centers
      4. By Regulatory Agencies
      5. By Other End Users
  6. BENELUX
    1. BENELUX Cell and Gene Therapy Manufacturing Market, By Type
      1. By Cell Therapy
      2. By Gene Therapy
    2. BENELUX Cell and Gene Therapy Manufacturing Market, By Indication
      1. By Oncology Diseases
      2. By Inherited Disorders
      3. By Cardiovascular Diseases
      4. By Musculoskeletal Disorders
      5. By Neurological Diseases
      6. By Other Indications
    3. BENELUX Cell and Gene Therapy Manufacturing Market, By Application
      1. By Clinical Manufacturing
      2. By Commercial Manufacturing
    4. BENELUX Cell and Gene Therapy Manufacturing Market, By End User
      1. By Pharmaceutical & Biotechnology Companies
      2. By Contract Manufacturing Organizations (CMOs)
      3. By Research Institutes & Academic Centers
      4. By Regulatory Agencies
      5. By Other End Users
  7. Rest of Europe
    1. Rest Of Europe Cell and Gene Therapy Manufacturing Market, By Type
      1. By Cell Therapy
      2. By Gene Therapy
    2. Rest Of Europe Cell and Gene Therapy Manufacturing Market, By Indication
      1. By Oncology Diseases
      2. By Inherited Disorders
      3. By Cardiovascular Diseases
      4. By Musculoskeletal Disorders
      5. By Neurological Diseases
      6. By Other Indications
    3. Rest Of Europe Cell and Gene Therapy Manufacturing Market, By Application
      1. By Clinical Manufacturing
      2. By Commercial Manufacturing
    4. Rest Of Europe Cell and Gene Therapy Manufacturing Market, By End User
      1. By Pharmaceutical & Biotechnology Companies
      2. By Contract Manufacturing Organizations (CMOs)
      3. By Research Institutes & Academic Centers
      4. By Regulatory Agencies
      5. By Other End Users
Asia Pacific Cell and Gene Therapy Manufacturing Market - Segment Analysis
1. Overview
2. Asia Pacific Cell and Gene Therapy Manufacturing Market, 2016 - 2028 (USD Million)
3. Asia Pacific Cell and Gene Therapy Manufacturing Market, by Type
  1. By Cell Therapy
  2. By Gene Therapy
4. Asia Pacific Cell and Gene Therapy Manufacturing Market, by Indication
  1. By Oncology Diseases
  2. By Inherited Disorders
  3. By Cardiovascular Diseases
  4. By Musculoskeletal Disorders
  5. By Neurological Diseases
  6. By Other Indications
5. Asia Pacific Cell and Gene Therapy Manufacturing Market, by Application
  1. By Clinical Manufacturing
  2. By Commercial Manufacturing
6. Asia Pacific Cell and Gene Therapy Manufacturing Market, by End User
  1. By Pharmaceutical & Biotechnology Companies
  2. By Contract Manufacturing Organizations (CMOs)
  3. By Research Institutes & Academic Centers
  4. By Regulatory Agencies
  5. By Other End Users
7. Asia Pacific Cell and Gene Therapy Manufacturing Market, by Country
  1. China
    1. China Cell and Gene Therapy Manufacturing Market, By Type
      1. By Cell Therapy
      2. By Gene Therapy
    2. China Cell and Gene Therapy Manufacturing Market, By Indication
      1. By Oncology Diseases
      2. By Inherited Disorders
      3. By Cardiovascular Diseases
      4. By Musculoskeletal Disorders
      5. By Neurological Diseases
      6. By Other Indications
    3. China Cell and Gene Therapy Manufacturing Market, By Application
      1. By Clinical Manufacturing
      2. By Commercial Manufacturing
    4. China Cell and Gene Therapy Manufacturing Market, By End User
      1. By Pharmaceutical & Biotechnology Companies
      2. By Contract Manufacturing Organizations (CMOs)
      3. By Research Institutes & Academic Centers
      4. By Regulatory Agencies
      5. By Other End Users
  2. Japan
    1. Japan Cell and Gene Therapy Manufacturing Market, By Type
      1. By Cell Therapy
      2. By Gene Therapy
    2. Japan Cell and Gene Therapy Manufacturing Market, By Indication
      1. By Oncology Diseases
      2. By Inherited Disorders
      3. By Cardiovascular Diseases
      4. By Musculoskeletal Disorders
      5. By Neurological Diseases
      6. By Other Indications
    3. Japan Cell and Gene Therapy Manufacturing Market, By Application
      1. By Clinical Manufacturing
      2. By Commercial Manufacturing
    4. Japan Cell and Gene Therapy Manufacturing Market, By End User
      1. By Pharmaceutical & Biotechnology Companies
      2. By Contract Manufacturing Organizations (CMOs)
      3. By Research Institutes & Academic Centers
      4. By Regulatory Agencies
      5. By Other End Users
  3. India
    1. India Cell and Gene Therapy Manufacturing Market, By Type
      1. By Cell Therapy
      2. By Gene Therapy
    2. India Cell and Gene Therapy Manufacturing Market, By Indication
      1. By Oncology Diseases
      2. By Inherited Disorders
      3. By Cardiovascular Diseases
      4. By Musculoskeletal Disorders
      5. By Neurological Diseases
      6. By Other Indications
    3. India Cell and Gene Therapy Manufacturing Market, By Application
      1. By Clinical Manufacturing
      2. By Commercial Manufacturing
    4. India Cell and Gene Therapy Manufacturing Market, By End User
      1. By Pharmaceutical & Biotechnology Companies
      2. By Contract Manufacturing Organizations (CMOs)
      3. By Research Institutes & Academic Centers
      4. By Regulatory Agencies
      5. By Other End Users
  4. South Korea
    1. South Korea Cell and Gene Therapy Manufacturing Market, By Type
      1. By Cell Therapy
      2. By Gene Therapy
    2. South Korea Cell and Gene Therapy Manufacturing Market, By Indication
      1. By Oncology Diseases
      2. By Inherited Disorders
      3. By Cardiovascular Diseases
      4. By Musculoskeletal Disorders
      5. By Neurological Diseases
      6. By Other Indications
    3. South Korea Cell and Gene Therapy Manufacturing Market, By Application
      1. By Clinical Manufacturing
      2. By Commercial Manufacturing
    4. South Korea Cell and Gene Therapy Manufacturing Market, By End User
      1. By Pharmaceutical & Biotechnology Companies
      2. By Contract Manufacturing Organizations (CMOs)
      3. By Research Institutes & Academic Centers
      4. By Regulatory Agencies
      5. By Other End Users
  5. South East Asia
    1. South East Asia Cell and Gene Therapy Manufacturing Market, By Type
      1. By Cell Therapy
      2. By Gene Therapy
    2. South East Asia Cell and Gene Therapy Manufacturing Market, By Indication
      1. By Oncology Diseases
      2. By Inherited Disorders
      3. By Cardiovascular Diseases
      4. By Musculoskeletal Disorders
      5. By Neurological Diseases
      6. By Other Indications
    3. South East Asia Cell and Gene Therapy Manufacturing Market, By Application
      1. By Clinical Manufacturing
      2. By Commercial Manufacturing
    4. South East Asia Cell and Gene Therapy Manufacturing Market, By End User
      1. By Pharmaceutical & Biotechnology Companies
      2. By Contract Manufacturing Organizations (CMOs)
      3. By Research Institutes & Academic Centers
      4. By Regulatory Agencies
      5. By Other End Users
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Cell and Gene Therapy Manufacturing Market, By Type
      1. By Cell Therapy
      2. By Gene Therapy
    2. Rest of Asia Pacific Cell and Gene Therapy Manufacturing Market, By Indication
      1. By Oncology Diseases
      2. By Inherited Disorders
      3. By Cardiovascular Diseases
      4. By Musculoskeletal Disorders
      5. By Neurological Diseases
      6. By Other Indications
    3. Rest of Asia Pacific Cell and Gene Therapy Manufacturing Market, By Application
      1. By Clinical Manufacturing
      2. By Commercial Manufacturing
    4. Rest of Asia Pacific Cell and Gene Therapy Manufacturing Market, By End User
      1. By Pharmaceutical & Biotechnology Companies
      2. By Contract Manufacturing Organizations (CMOs)
      3. By Research Institutes & Academic Centers
      4. By Regulatory Agencies
      5. By Other End Users
Latin America Cell and Gene Therapy Manufacturing Market - Segment Analysis
1. Overview
2. Latin America Cell and Gene Therapy Manufacturing Market, 2016 - 2028 (USD Million)
3. Latin America Cell and Gene Therapy Manufacturing Market, by Type
  1. By Cell Therapy
  2. By Gene Therapy
4. Latin America Cell and Gene Therapy Manufacturing Market, by Indication
  1. By Oncology Diseases
  2. By Inherited Disorders
  3. By Cardiovascular Diseases
  4. By Musculoskeletal Disorders
  5. By Neurological Diseases
  6. By Other Indications
5. Latin America Cell and Gene Therapy Manufacturing Market, by Application
  1. By Clinical Manufacturing
  2. By Commercial Manufacturing
6. Latin America Cell and Gene Therapy Manufacturing Market, by End User
  1. By Pharmaceutical & Biotechnology Companies
  2. By Contract Manufacturing Organizations (CMOs)
  3. By Research Institutes & Academic Centers
  4. By Regulatory Agencies
  5. By Other End Users
7. Latin America Cell and Gene Therapy Manufacturing Market, by Country
  1. Brazil
    1. Brazil Cell and Gene Therapy Manufacturing Market, By Type
      1. By Cell Therapy
      2. By Gene Therapy
    2. Brazil Cell and Gene Therapy Manufacturing Market, By Indication
      1. By Oncology Diseases
      2. By Inherited Disorders
      3. By Cardiovascular Diseases
      4. By Musculoskeletal Disorders
      5. By Neurological Diseases
      6. By Other Indications
    3. Brazil Cell and Gene Therapy Manufacturing Market, By Application
      1. By Clinical Manufacturing
      2. By Commercial Manufacturing
    4. Brazil Cell and Gene Therapy Manufacturing Market, By End User
      1. By Pharmaceutical & Biotechnology Companies
      2. By Contract Manufacturing Organizations (CMOs)
      3. By Research Institutes & Academic Centers
      4. By Regulatory Agencies
      5. By Other End Users
  2. Argentina
    1. Argentina Cell and Gene Therapy Manufacturing Market, By Type
      1. By Cell Therapy
      2. By Gene Therapy
    2. Argentina Cell and Gene Therapy Manufacturing Market, By Indication
      1. By Oncology Diseases
      2. By Inherited Disorders
      3. By Cardiovascular Diseases
      4. By Musculoskeletal Disorders
      5. By Neurological Diseases
      6. By Other Indications
    3. Argentina Cell and Gene Therapy Manufacturing Market, By Application
      1. By Clinical Manufacturing
      2. By Commercial Manufacturing
    4. Argentina Cell and Gene Therapy Manufacturing Market, By End User
      1. By Pharmaceutical & Biotechnology Companies
      2. By Contract Manufacturing Organizations (CMOs)
      3. By Research Institutes & Academic Centers
      4. By Regulatory Agencies
      5. By Other End Users
  3. Rest of Latin America
    1. Rest of Latin America Cell and Gene Therapy Manufacturing Market, By Type
      1. By Cell Therapy
      2. By Gene Therapy
    2. Rest of Latin America Cell and Gene Therapy Manufacturing Market, By Indication
      1. By Oncology Diseases
      2. By Inherited Disorders
      3. By Cardiovascular Diseases
      4. By Musculoskeletal Disorders
      5. By Neurological Diseases
      6. By Other Indications
    3. Rest of Latin America Cell and Gene Therapy Manufacturing Market, By Application
      1. By Clinical Manufacturing
      2. By Commercial Manufacturing
    4. Rest of Latin America Cell and Gene Therapy Manufacturing Market, By End User
      1. By Pharmaceutical & Biotechnology Companies
      2. By Contract Manufacturing Organizations (CMOs)
      3. By Research Institutes & Academic Centers
      4. By Regulatory Agencies
      5. By Other End Users
Middle East & Africa Cell and Gene Therapy Manufacturing Market - Segment Analysis
1. Overview
2. Middle East & Africa Cell and Gene Therapy Manufacturing Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Cell and Gene Therapy Manufacturing Market, by Type
  1. By Cell Therapy
  2. By Gene Therapy
4. Middle East & Africa Cell and Gene Therapy Manufacturing Market, by Indication
  1. By Oncology Diseases
  2. By Inherited Disorders
  3. By Cardiovascular Diseases
  4. By Musculoskeletal Disorders
  5. By Neurological Diseases
  6. By Other Indications
5. Middle East & Africa Cell and Gene Therapy Manufacturing Market, by Application
  1. By Clinical Manufacturing
  2. By Commercial Manufacturing
6. Middle East & Africa Cell and Gene Therapy Manufacturing Market, by End User
  1. By Pharmaceutical & Biotechnology Companies
  2. By Contract Manufacturing Organizations (CMOs)
  3. By Research Institutes & Academic Centers
  4. By Regulatory Agencies
  5. By Other End Users
7. Middle East & Africa Cell and Gene Therapy Manufacturing Market, by Country
  1. GCC Countries
    1. GCC Countries Cell and Gene Therapy Manufacturing Market, By Type
      1. By Cell Therapy
      2. By Gene Therapy
    2. GCC Countries Cell and Gene Therapy Manufacturing Market, By Indication
      1. By Oncology Diseases
      2. By Inherited Disorders
      3. By Cardiovascular Diseases
      4. By Musculoskeletal Disorders
      5. By Neurological Diseases
      6. By Other Indications
    3. GCC Countries Cell and Gene Therapy Manufacturing Market, By Application
      1. By Clinical Manufacturing
      2. By Commercial Manufacturing
    4. GCC Countries Cell and Gene Therapy Manufacturing Market, By End User
      1. By Pharmaceutical & Biotechnology Companies
      2. By Contract Manufacturing Organizations (CMOs)
      3. By Research Institutes & Academic Centers
      4. By Regulatory Agencies
      5. By Other End Users
  2. South Africa
    1. South Africa Cell and Gene Therapy Manufacturing Market, By Type
      1. By Cell Therapy
      2. By Gene Therapy
    2. South Africa Cell and Gene Therapy Manufacturing Market, By Indication
      1. By Oncology Diseases
      2. By Inherited Disorders
      3. By Cardiovascular Diseases
      4. By Musculoskeletal Disorders
      5. By Neurological Diseases
      6. By Other Indications
    3. South Africa Cell and Gene Therapy Manufacturing Market, By Application
      1. By Clinical Manufacturing
      2. By Commercial Manufacturing
    4. South Africa Cell and Gene Therapy Manufacturing Market, By End User
      1. By Pharmaceutical & Biotechnology Companies
      2. By Contract Manufacturing Organizations (CMOs)
      3. By Research Institutes & Academic Centers
      4. By Regulatory Agencies
      5. By Other End Users
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Cell and Gene Therapy Manufacturing Market, By Type
      1. By Cell Therapy
      2. By Gene Therapy
    2. Rest of Middle East & Africa Cell and Gene Therapy Manufacturing Market, By Indication
      1. By Oncology Diseases
      2. By Inherited Disorders
      3. By Cardiovascular Diseases
      4. By Musculoskeletal Disorders
      5. By Neurological Diseases
      6. By Other Indications
    3. Rest of Middle East & Africa Cell and Gene Therapy Manufacturing Market, By Application
      1. By Clinical Manufacturing
      2. By Commercial Manufacturing
    4. Rest of Middle East & Africa Cell and Gene Therapy Manufacturing Market, By End User
      1. By Pharmaceutical & Biotechnology Companies
      2. By Contract Manufacturing Organizations (CMOs)
      3. By Research Institutes & Academic Centers
      4. By Regulatory Agencies
      5. By Other End Users
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Lonza (Switzerland)
2. Bluebird Bio (U.S.)
3. Catalent Inc. (U.S.)
4. F. Hoffmann-La Roche Ltd. (Switzerland)
5. Samsung Biologics (South Korea)
6. Boehringer Ingelheim (Germany)
7. Cellular Therapeutics (China)
8. Hitachi Chemical Co. Ltd. (Japan)
9. Takara Bio Inc. (Japan)
10. Miltenyi Biotec (U.S.)
11. Thermo Fisher Scientific (U.S.)
12. Novartis International AG (Switzerland)
13. Merck KGaA (Germany)
14. Wuxi Advanced Therapies (U.S.)
15. Fujifilm Holdings Corp. (Japan)
16. Charles River Laboratories International Inc. (U.S.)
17. GE Healthcare Life Sciences (U.S.)
18. CGT Catapult (UK)
19. CoJourney Inc. (China)
20. ElevateBio LLC (U.S.)
21. Pfizer Inc. (U.S.) Inc.te Corp. (U.S.)
22. AllogeneTherapeutics Inc. (U.S.)
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

Vantage Market Research | 01-Aug-2023

Cell and Gene Therapy Manufacturing Market to Reach Valuation of USD 15.4 Billion by 2030 – Growth in the Usage of Advanced Biotechnology and Genetic Engineering Techniques Drive The Market

FAQ

Frequently Asked Question

What is the global demand for Cell and Gene Therapy Manufacturing in terms of revenue?

The global Cell and Gene Therapy Manufacturing valued at USD 4.8 Billion in 2022 and is expected to reach USD 15.4 Billion in 2030 growing at a CAGR of 18.2%.

Which are the prominent players in the market?

The prominent players in the market are Lonza (Switzerland), Bluebird Bio (U.S.), Catalent Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Samsung Biologics (South Korea), Boehringer Ingelheim (Germany), Cellular Therapeutics (China), Hitachi Chemical Co. Ltd. (Japan), Takara Bio Inc. (Japan), Miltenyi Biotec (U.S.), Thermo Fisher Scientific (U.S.), Novartis International AG (Switzerland), Merck KGaA (Germany), Wuxi Advanced Therapies (U.S.), Fujifilm Holdings Corp. (Japan), Charles River Laboratories International Inc. (U.S.), GE Healthcare Life Sciences (U.S.), CGT Catapult (UK), CoJourney Inc. (China), ElevateBio LLC (U.S.), Pfizer Inc. (U.S.), Incyte Corp. (U.S.), AllogeneTherapeutics Inc. (U.S.).

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 18.2% between 2023 and 2030.

What are the driving factors fueling the growth of the market.

The driving factors of the Cell and Gene Therapy Manufacturing include
- High incidence of cancer and other target diseases

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Cell and Gene Therapy Manufacturing in 2022.

Cell and Gene Therapy Manufacturing Market

Cell and Gene Therapy Manufacturing Market - Global Industry Assessment & Forecast

Biotechnology and Life Sciences

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Cell and Gene Therapy Manufacturing in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Quick Links

For Buying Inquiry

Cell and Gene Therapy Manufacturing Market

Cell and Gene Therapy Manufacturing Market - Global Industry Assessment & Forecast

Biotechnology and Life Sciences

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Cell and Gene Therapy Manufacturing in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Cell and Gene Therapy Manufacturing Market

Vantage Point Interactive Dashboard